Are Options Traders Bullish on ASND?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ASND

Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best-in-class therapeutics that address significant unmet medical needs.The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The Ascendis Pharma pipeline includes TransCon Growth Hormone, a proprietary program that has completed Phase 2 studies in adults and children with growth hormone deficiency, or GHD. Ascendis Pharma expects to initiate a Phase 3 pediatric study of TransCon Growth Hormone in mid-2016. Ascendis Pharma is also developing its wholly-owned TransCon Treprostinil for the treatment of pulmonary arterial hypertension, or PAH. In addition to its proprietary programs, Ascendis Pharma has formed collaborations focused on leading products in large markets that are of strategic importance to its collaboration partners. These collaborations are with Sanofi in diabetes and Genentech in the field of ophthalmology.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ASND is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ADRU Invesco BLDRS Europe Select ADR Index Fund 13.2 M 1.32E+07 74 74 0.04% 0.00042 6 K 5525
ADRD Invesco BLDRS Developed Markets 100 ADR Index Fund 49.1 M 4.91E+07 86 86 0.04% 0.00035 17 K 17169
BIB ProShares Ultra Nasdaq Biotechnology 283.8 M 2.83842E+08 202 202 0.15% 0.00146799 864 K 863816
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.00963E+09 191 191 0.33% 0.0033 26.9 M 2.6891E+07
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.02% 0.000236323 437 K 437317
SBIO ALPS Medical Breakthroughs ETF 221.8 M 2.21846E+08 112 112 1.62% 0.0162 3.6 M 3593905
UBIO Proshares UltraPro Nasdaq Biotechnology 28.8 M 2.87594E+07 196 196 0.07% 0.000689598 66 K 65578

Wait, Before You Leave...